Imiquimod for actinic keratosis: systematic review and meta-analysis.
about
Interventions for actinic keratosesAdvances in the use of topical imiquimod to treat dermatologic disordersThe phenotypic legacy of admixture between modern humans and NeandertalsPharmacotherapy of actinic keratosis.Kaposi's sarcoma responding to topical imiquimod 5% cream: a case report.Visualization and treatment of subclinical actinic keratoses with topical imiquimod 5% cream: an observational study.Actinic keratosis: rationale and managementActinic keratoses: a comprehensive updateFluorouracil cream 0.5% for the treatment of actinic keratoses on the face and anterior scalp: interim results of an 18-month open-label studyPharmacotherapy of actinic keratosis: an update.Actinic keratosis: update on field therapy.Impact of different vehicles for laser-assisted drug permeation via skin: full-surface versus fractional ablation.A network meta-analysis of the relative efficacy of treatments for actinic keratosis of the face or scalp in EuropeDevelopment of nanovesicular systems for dermal imiquimod delivery: physicochemical characterization and in vitro/in vivo evaluation.Imiquimod attenuates the growth of UVB-induced SCC in mice through Th1/Th17 cells.TLR7 and TLR8 as targets in cancer therapy.What's new in dermatologic therapy.In vitro effects of tetraiodothyroacetic acid combined with X-irradiation on basal cell carcinoma cells.Treating skin cancer with topical cream.Targeting the tumor microenvironment by immunotherapy: part 2.Medical approaches to non-melanoma skin cancer.TLRs to cytokines: mechanistic insights from the imiquimod mouse model of psoriasis.Imiquimod in dermatology: an overview.Cellulitis Secondary to Liquid Nitrogen Cryotherapy: Case Report and Literature Review.Cancer immunotherapeutic potential of novel small molecule TLR7 and TLR8 agonists.British Association of Dermatologists' guidelines for the care of patients with actinic keratosis 2017.Novel Fish Oil-based Bigel System for Controlled Drug Delivery and its Influence on Immunomodulatory Activity of Imiquimod Against Skin Cancer.
P2860
Q24202407-9E4187DC-6D52-4B50-AB00-BEB65D2E9356Q24647413-45500272-3C95-49D1-B18E-39E5AFD82391Q28603615-9EF6BB83-AE3E-42C1-A97D-19512A2E57E2Q30898080-1427D212-1D9F-421E-A442-3E077AA5D7ADQ33681669-510F3D5B-251C-43A2-B8C3-37E592DA82D5Q33681786-4EA218E4-1ECF-4E70-9343-64F812638619Q33785049-DF139DD4-A34A-4BED-9ECD-44CA553AD6DFQ34132659-CA1EC47D-0C7F-471F-897C-925E55476C6FQ34340861-3F3D9118-CA5E-4553-B5C8-11316BB9E7A3Q34378153-1D6F4D69-8B06-4E55-8892-E928053DD525Q34441431-13D4BD19-C151-4310-BF70-57459958FB69Q34983358-624036E6-60C4-4D70-8E17-10BDFB72D48EQ35180653-217402D3-F3A0-42A1-B51A-FC1B5F138CA1Q35635404-C27EC12B-1FF8-4A5B-8A71-3BDC1406253FQ36096165-CDB53C1C-05DD-4C51-9C40-EC0D50EA0465Q37051014-29E7C59E-A6FB-484D-BB43-503B5654297FQ37131029-3BF989F4-DF66-4DC2-8850-BFD570428CF6Q37664293-ADFDB4A3-AC35-448B-9FE1-D427EBC0F520Q37735187-068F620E-6641-4AEF-BBE4-81B2C783E44EQ37952796-8444DB1C-0155-487B-8DDB-1100C077732EQ38162923-B5511ECD-1DD3-4C55-ADA6-32A18348682FQ38164289-0BCF8136-8788-4F18-B5F4-62AB4EBCE2DEQ38888889-3A8F9CB6-DB05-48B3-9C7C-A276BD20AB7FQ39208830-0BD7710D-0D86-49D6-B64C-172C0364C739Q39784591-19A6D3C8-1B14-4DFC-8175-61762198C19FQ48063272-80E9464C-8894-4B51-9ECC-AD1EF3102F5DQ50584399-54D4C231-DD6D-476D-86A8-64B80659BFC9
P2860
Imiquimod for actinic keratosis: systematic review and meta-analysis.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Imiquimod for actinic keratosis: systematic review and meta-analysis.
@ast
Imiquimod for actinic keratosis: systematic review and meta-analysis.
@en
Imiquimod for actinic keratosis: systematic review and meta-analysis.
@nl
type
label
Imiquimod for actinic keratosis: systematic review and meta-analysis.
@ast
Imiquimod for actinic keratosis: systematic review and meta-analysis.
@en
Imiquimod for actinic keratosis: systematic review and meta-analysis.
@nl
prefLabel
Imiquimod for actinic keratosis: systematic review and meta-analysis.
@ast
Imiquimod for actinic keratosis: systematic review and meta-analysis.
@en
Imiquimod for actinic keratosis: systematic review and meta-analysis.
@nl
P356
P1476
Imiquimod for actinic keratosis: systematic review and meta-analysis.
@en
P2093
Gina Hadley
Robert A Moore
P2888
P304
P356
10.1038/SJ.JID.5700264
P407
P50
P577
2006-06-01T00:00:00Z
P5875
P6179
1017417849